Dennis D. Kim - 17 May 2021 Form 4 Insider Report for CymaBay Therapeutics, Inc.

Role
Chief Medical Officer
Signature
/s/ Paul Quinlan, as attorney-in-fact for Dennis D. Kim
Issuer symbol
N/A
Transactions as of
17 May 2021
Net transactions value
$0
Form type
4
Filing time
17 May 2021, 18:57:47 UTC
Next filing
20 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CBAY Employee Stock Option (right to buy) Award $0 +390,000 $0.000000 390,000 17 May 2021 Common Stock 390,000 $4.37 Direct F1
transaction CBAY Employee Stock Option (right to buy) Award $0 +10,000 $0.000000 10,000 17 May 2021 Common Stock 10,000 $4.37 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 1/4 of the underlying shares on May 17, 2022 and vests as to 1/48 of the underlying shares monthly thereafter.